...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease.
【24h】

Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease.

机译:二尖瓣糖胺聚糖的精细表征及其在变性疾病中的修饰。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The levels and fine structure of complex polysaccharides, glycosaminoglycans (GAGs), were determined in segments of the posterior mitral valve leaflet (MVL) taken from 15 patients affected by mitral regurgitation and degenerative disease and were compared with segments from 15 multiorgan donors. METHODS: MVL GAGs were analyzed by agarose gel electrophoresis, and by HPLC and fluorophore-assisted carbohydrate electrophoresis to evaluate disaccharide patterns after treatment with chondroitinase ABC. RESULTS: GAGs from the control group were composed of approximately 37% hyaluronic acid and 63% chondroitin sulfate/dermatan sulfate with a charge density of approximately 0.61. Chondroitin sulfate/dermatan sulfate polymers contained approximately 23% of the disaccharide sulfated in position 6 on N-acetyl-galactosamine, approximately 38% of the 4-sulfated disaccharide and approximately 2% of the non-sulfated disaccharide (with a 4-sulfated/6-sulfated ratio of 1.7). The total amount of GAGs was 0.66microg/mg tissue. The total amount of GAGs in patients suffering from mitral regurgitation and degenerative disease was approximately 51.5% higher (although the difference was not significant, probably because of the low number of subjects enrolled in the study). However, significantly higher hyaluronic acid content (approx. +38%, p<0.05) and lower sulfated GAG content (approx. -21%, p<0.005) were demonstrated. As a consequence, the total charge density decreased by approximately 23% (p<0.005). This macro-modification of GAG composition was also followed by a micro-alteration of the structure of the sulfated polysaccharides, in particular with a significant decrease in the 4-sulfated disaccharide (and a parallel increase in hyaluronic acid content) with no modification of the percentage of the 6-sulfated and non-sulfated disaccharides (with a significant decrease in the 4-/6-sulfated ratio). CONCLUSIONS: We assume that changes in the relative amount and distribution of GAGs in posterior MVL in subjects suffering from mitral regurgitation and degenerative disease are consistent with a decrease in the tension to which these tissues are subjected and with an abnormal matrix microstructure capable of influencing the hydration and of conditioning the mechanical weakness of these pathological tissues.
机译:背景:从15例二尖瓣反流和退行性疾病患者的二尖瓣后叶(MVL)的片段中确定了复合多糖糖胺聚糖(GAGs)的水平和精细结构,并将其与15个多器官供体的片段进行了比较。方法:采用琼脂糖凝胶电泳,高效液相色谱和荧光辅助糖电泳对MVL GAG进行分析,以评价软骨素酶ABC处理后的二糖模式。结果:对照组的GAG由约37%的透明质酸和63%的硫酸软骨素/硫酸皮肤素组成,电荷密度约为0.61。硫酸软骨素/硫酸皮肤素聚合物包含约23%的N-乙酰基-半乳糖胺上的位置6硫酸化的二糖,约38%的4-硫酸化的二糖和约2%的非硫酸化的二糖(其中4-硫酸化/六硫酸化比为1.7)。 GAG的总量为0.66microg / mg组织。二尖瓣反流和退行性疾病患者的GAG总量高出约51.5%(尽管差异不显着,可能是因为该研究的受试者人数较少)。然而,显示出明显更高的透明质酸含量(约+ 38%,p <0.05)和更低的硫酸化GAG含量(约-21%,p <0.005)。结果,总电荷密度降低了约23%(p <0.005)。在对GAG组成进行宏观修饰后,硫酸化多糖的结构也发生了微变化,特别是4-硫酸化二糖的显着减少(透明质酸含量同时增加),而没有改变。 6-硫酸盐和非硫酸盐二糖的百分比(4-硫酸盐比率明显降低)。结论:我们认为二尖瓣反流和退行性疾病的受试者后MVL中GAGs相对数量和分布的变化与这些组织所承受的张力降低以及能够影响组织的异常基质微观结构一致。补充水分,调节这些病理组织的机械功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号